Neublastin

BG00010 · Biogen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Neublastin, covering 2015-02-09 to 2015-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Subcutaneous Single and Multiple Ascending Dose Study of BG00010 (Neublastin) [Phase 1]